<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1122490742015118&amp;ev=PageView&amp;noscript=1">
The HALT Study
The HALT Study

What is HALT?

The HALT Study is a double blinded, randomized, placebo-controlled trial to determine the effectiveness of TRIV202 in managing left ventricular hypertrophy associated with feline subclinical hypertrophic cardiomyopathy (HCM) over 12 months. The study will be conducted at various cardiac centers across the US with more to be added over time. It will aim to enrol 300 cats.

Where is HALT taking place?

The HALT Study will be taking place in the below cardiac care centers across the US, with more to be added over time. Select the site closest to you and if you don't see one in your City/State select other and fill out the general form and you will be notified of any new sites!

20 sites as of 24 may 2024

Study Sites

Rohnert Park, California Sacramento, California
San Juan Capistrano, California South Bay Los Angeles, California
West Los Angeles, California West Palm Beach, Florida
Louisville, Kentucky Frederick, Maryland
Lawrence, Massachusetts Woburn, Massachusetts
Manchester, Missouri Reno, Nevada
Portsmouth, New Hampshire Charlotte, North Carolina
Akron, Ohio Greenville, South Carolina
Fairfax, Virginia Richmond, Virginia
Everett, Washington Waukesha, Wisconsin


Register your interest for The HALT Study below

Rohnert Park, CA
Sacramento, CA
San Juan Capistrano, CA
South Bay - LA, CA
West LA, CA
West Palm Beach, FL
Louisville, KY
Frederick, MD
Lawrence, MA
Woburn, MA
Manchester, MO
Reno, NV
Portsmouth, NH
Charlotte, NC
Akron, OH
Greenville, SC
Fairfax, VA
Richmond, VA
Everett, WA
Waukesha, WI
No site in your area/country? Fill in our interest form to receive future updates on feline HCM research in the Rest of World.

Download content